# Continuous Subcutaneous Insulin Infusion strAtegy Versus Multiple Daily Insulin Injections strAtegy

Study · id `cardio:ct-nct01574508` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01574508](<https://clinicaltrials.gov/study/NCT01574508>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01574508

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

## Technical summary

Registry record NCT01574508. Randomized; no masking; primary purpose treatment. Start 2011-12 (registry gives no type); primary completion 2013-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT01574508, source copy `cardio:ctgov-nct01574508-2013-05-06`, retrieved 2026-10-26)
- Start date: 2011-12 (registry gives no type) (ClinicalTrials.gov record NCT01574508, source copy `cardio:ctgov-nct01574508-2013-05-06`, retrieved 2026-10-26)
- Primary completion: 2013-12 (anticipated) (ClinicalTrials.gov record NCT01574508, source copy `cardio:ctgov-nct01574508-2013-05-06`, retrieved 2026-10-26)
- Completion: 2014-12 (anticipated) (ClinicalTrials.gov record NCT01574508, source copy `cardio:ctgov-nct01574508-2013-05-06`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT01574508, source copy `cardio:ctgov-nct01574508-2013-05-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01574508-2013-05-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: Continuous Subcutaneous Insulin Infusion strAtegy Versus Multiple Daily Insulin Injections strAtegy
- Acronym: CAMACS
- Condition: Type 2 Diabetes
- Intervention (Drug): Transient Continuous Subcutaneous Insulin Infusion
- Intervention (Drug): Transient Multiple Daily Insulin Injections
- Lead sponsor: Shanghai Jiao Tong University School of Medicine
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Shanghai Jiao Tong University School of Medicine (`cardio:org-shanghai-jiao-tong-university-school-of-medicine`)

## Provenance

Content hash: e8a7850af895618b2278cfb36d6be4d130820f8fb422549dc76e7bb886088d31
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
